Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI.
Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis.
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure.
Is there a cognitive signature for MS-related fatigue?
GM-CSF promotes migration of human monocytes across the blood brain barrier.
AQP4 antibody serostatus: Is its luster being lost in the management and pathogenesis of NMO?
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
[LINGO-1 Expression of brain tissue in Experimental Autoimmune Encephalomyelitis Mouse].
A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis.
Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - NO.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
[Diagnosis and differential diagnosis of demyelinating optic neuropathy in multiple sclerosis.]
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Participant perceptions of a novel physiotherapy approach ("Blue Prescription") for increasing levels of physical activity in people with multiple sclerosis: a qualitative study following intervention.
Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1.
Artificial reproductive techniques in multiple sclerosis.
Overexpression of SIRT1 Protein in Neurons Protects against Experimental Autoimmune Encephalomyelitis through Activation of Multiple SIRT1 Targets.
Education protects against cognitive changes associated with multiple sclerosis.
Analysis of HLA-DQB1*0602 in Multiple Sclerosis Patients in Khuzestan Province, Iran.
Stage-Specific Regulation of Oligodendrocyte Development by Wnt/β-Catenin Signaling.
European multiple sclerosis risk variants in the south Asian population.
Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis.
Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules.
Pages
« first
‹ previous
…
495
496
497
498
499
500
501
502
503
…
next ›
last »